PubMed

Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program.

Kirkman MS, Shankar RR, Shankar S, Shen C, Brizendine E, Baron A, McGill J.

Diabetes Care. 2006 Sep;29(9):2095-101.PMID: 16936159 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of acarbose on insulin sensitivity in elderly patients with diabetes.

Meneilly GS, Ryan EA, Radziuk J, Lau DC, Yale JF, Morais J, Chiasson JL, Rabasa-Lhoret R, Maheux P, Tessier D, Wolever T, Josse RG, Elahi D.

Diabetes Care. 2000 Aug;23(8):1162-7.PMID: 10937515 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.

Yamagishi S, Nakamura K, Takeuchi M.

Med Hypotheses. 2005;65(1):152-4. Epub 2005 Jan 28.PMID: 15893133 [PubMed - indexed for MEDLINE]Related articles

Postprandial glucose regulation: new data and new implications.

Leiter LA, Ceriello A, Davidson JA, Hanefeld M, Monnier L, Owens DR, Tajima N, Tuomilehto J; International Prandial Glucose Regulation Study Group.

Clin Ther. 2005;27 Suppl B:S42-56. Review.PMID: 16519037 [PubMed - indexed for MEDLINE]Related articles

Effect of lowering postprandial hyperglycemia on insulin secretion in older people with impaired glucose tolerance.

Chang AM, Smith MJ, Bloem CJ, Galecki AT, Halter JB.

Am J Physiol Endocrinol Metab. 2004 Nov;287(5):E906-11. Epub 2004 Jun 22.PMID: 15213063 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy of acarbose in Chinese subjects with impaired glucose tolerance.

Pan CY, Gao Y, Chen JW, Luo BY, Fu ZZ, Lu JM, Guo XH, Cheng H.

Diabetes Res Clin Pract. 2003 Sep;61(3):183-90.PMID: 12965108 [PubMed - indexed for MEDLINE]Related articles

Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia.

Suzuki H, Fukushima M, Usami M, Ikeda M, Taniguchi A, Nakai Y, Matsuura T, Kuroe A, Yasuda K, Kurose T, Seino Y, Yamada Y.

Diabetes Care. 2003 Apr;26(4):1211-5.PMID: 12663599 [PubMed - indexed for MEDLINE]Related articlesFree article

The addition of acarbose to insulin lispro reduces acute glycaemic responses in patients with type-2 diabetes.

Hermanns N, Burkert A, Haak T.

Exp Clin Endocrinol Diabetes. 2004 Jun;112(6):310-4.PMID: 15216448 [PubMed - indexed for MEDLINE]Related articles

The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.

Rosak C, Haupt E, Walter T, Werner J.

Diabetes Nutr Metab. 2002 Jun;15(3):143-51.PMID: 12173728 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.

Rosak C, Hofmann U, Paulwitz O.

Diabetes Nutr Metab. 2004 Jun;17(3):137-42.PMID: 15334790 [PubMed - indexed for MEDLINE]Related articles

Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.

Carroll MF, Izard A, Riboni K, Burge MR, Schade DS.

Diabetes Care. 2002 Dec;25(12):2147-52.PMID: 12453952 [PubMed - indexed for MEDLINE]Related articlesFree article

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.

Henkel E, Menschikowski M, Koehler C, Leonhardt W, Hanefeld M.

Metabolism. 2005 Sep;54(9):1168-73.PMID: 16125528 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Rosenstock J, Brazg R, Andryuk PJ, Lu K, Stein P; Sitagliptin Study 019 Group.

Clin Ther. 2006 Oct;28(10):1556-68.PMID: 17157112 [PubMed - indexed for MEDLINE]Related articles

Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance.

Derosa G, Cicero AF, D'Angelo A, Ragonesi PD, Ciccarelli L, Fogari E, Salvadeo SA, Ferrari I, Gravina A, Fassi R, Fogari R.

Clin Drug Investig. 2006;26(9):529-39.PMID: 17163286 [PubMed - indexed for MEDLINE]Related articles

[Progress in the prevention of type 2 diabetes]

Schernthaner G.

Wien Klin Wochenschr. 2003 Nov 28;115(21-22):745-57. Review. German. PMID: 14743578 [PubMed - indexed for MEDLINE]Related articles

Acarbose improves glycemic control in insulin-treated Asian type 2 diabetic patients: results from a multinational, placebo-controlled study.

Hwu CM, Ho LT, Fuh MM, Siu SC, Sutanegara D, Piliang S, Chan JC; Asian Acarbose Study Group.

Diabetes Res Clin Pract. 2003 May;60(2):111-8.PMID: 12706319 [PubMed - indexed for MEDLINE]Related articles

Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.

Abdul-Ghani MA, Williams K, DeFronzo R, Stern M.

Diabetes Care. 2006 Jul;29(7):1613-8.PMID: 16801587 [PubMed - indexed for MEDLINE]Related articlesFree article

Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes.

Hanefeld M, Haffner SM, Menschikowski M, Koehler C, Temelkova-Kurktschiev T, Wildbrett J, Fischer S.

Diabetes Res Clin Pract. 2002 Mar;55(3):221-7.PMID: 11850098 [PubMed - indexed for MEDLINE]Related articles